Representative before the EPO

Company dna midas pharma gmbh
no operation time available
1 office
active in Legal Services

We have observed 6 EP applications Christian Drescher has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 19, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14187289

Pharmaceutical composition capable for the incorporation Febuxostat in the crystalline modifications F10, II, G and A

IPC classification:
A61K 9/20, A61K 9/16
Agent:
Christian Drescher, Midas Pharma GmbH
Status:
EXAMINATION REQUESTED
EP15160172

Immediate release dosage forms of Atomoxetine

IPC classification:
A61K 31/135, A61K 9/20
Applicant:
Salmon Pharma GmbH
Agent:
Christian Drescher, Midas Pharma GmbH
Status:
APPLICATION PUBLISHED
EP15165743

OPTIMIZED SYNTHESIS OF PREGABALIN AND 4-AMINO BUTANOIC ACID USING AN IMPROVED PRODUCTION METHOD OF CONJUGATED NITROALKENES

IPC classification:
C07C 227/04, C07C 205/51, C07C 205/03
Agent:
Christian Drescher, Midas Pharma GmbH
Status:
APPLICATION PUBLISHED
EP16160794

FIXED DOSED PHARMACEUTICAL COMPOSITION COMPRISING AMLODIPINE, CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE FOR THE TREATMENT OF HYPERTENSION

IPC classification:
A61K 31/549, A61K 31/4422, A61K 31/4184, A61K 9/20
Agent:
Christian Drescher, Midas Pharma GmbH
Status:
The application has been published
EP16173292

NON-CRYSTALLINE FORM OF PALBOCICLIB

IPC classification:
A61P 35/00, A61K 31/519, C07D 487/04
Agent:
Christian Drescher, Midas Pharma GmbH
Status:
The application has been published
EP16196240

METHOD FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS COMPRISING GADOLINIUM CHELATE COMPLEXES WITH REDUCED TOXIC CONTAMINATION

IPC classification:
A61K 49/10
Agent:
Christian Drescher, Midas Pharma GmbH
Status:
The application has been published

Please Sign in to use this feature